The publication of Eberhardt KE et al. proves that the IDK® anti-SARS-CoV-2 IgG ELISA is ideally suited for the quantitative detection of neutralizing antibodies after COVID-19 vaccination.
The Professional Association of German Laboratory Physicians recommends antibody tests before booster vaccinations, which could provide information about a possible protective effect.
Our goal is the development and production of diagnostics
We specialise in the development and production of innovative parameters and detection methods for laboratory diagnostics and medical research.
Our focus is the development of immunological detection methods for unoccupied niches.
Our development focuses on
- Risk identification of diseases
- Differential diagnostics
- Therapy monitoring
Our products include
- Immunoassays (ELISA, EIA)
- LC-MS/MS and HPLC applications
- Molecularbiological tests (PCR)
- Photometric tests
Our programme is completed by
- Poly- and monoclonal antibodies
- Research reagents
- Contract analytics
- Proficiency testing